新型流式细胞术检测「Flow IAT」揭示自身免疫性溶血性贫血中隐藏的IgM驱动补体激活
本研究开发了一种基于流式细胞术的新型间接抗人球蛋白试验(Flow IAT),用于评估AIHA患者血清中IgG和IgM与红细胞的结合及补体激活。研究纳入48例AIHA患者和21例对照,发现IgM结合与C4、C3沉积强相关,而IgG结合相关性差;Flow IAT检测IgM的敏感性优于传统方法,但检测IgG的敏感性较低。结果表明IgM在冷型和温型AIHA的补体激活中均起关键作用。
要点
- Flow IAT可量化循环抗红细胞抗体结合及抗体介导的补体激活。
- IgM结合与C4、C3沉积强相关,IgG结合相关性差。
- Flow IAT检测IgM敏感性优于传统方法,检测IgG敏感性较低。
核心结论
- Flow IAT成功识别补体激活型自身抗体,并证明IgM在冷型和温型AIHA中均与补体激活强相关。
研究设计与样本
- 研究开发了基于流式细胞术的间接抗人球蛋白试验(Flow IAT),使用菠萝蛋白酶处理的O型供者红细胞与AIHA患者血清(n=48)或对照(n=21)孵育,再与供者血清(补体来源)及抗C5共孵育后检测IgM、IgG、C4和C3调理。
主要发现
- IgM结合与C4和C3沉积强相关,而IgG结合相关性差。
- 按AIHA亚型分析时,IgM与C4的强相关依然存在。
- Flow IAT检测IgM抗体的敏感性优于传统诊断方法,但检测IgG的敏感性较低。
临床怎么用
- Flow IAT可用于检测循环抗红细胞抗体及抗体介导的补体激活,尤其有助于识别传统方法可能漏检的IgM型补体激活。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autoimmune hemolytic anemia (AIHA) is caused by antibody-driven red blood cell (RBC) destruction, which can involve complement activation. Correct detection of complement involvement in AIHA is now more relevant since the introduction of novel complement inhibitors. The Data Registry of AIHA (DRAIHA) study is a Dutch national cohort set up to investigate pathophysiology and diagnostic predictors. We developed a novel flow cytometry-based assay to assess serum-derived IgG and IgM binding and complement activation in AIHA and used this assay to analyze categorized DRAIHA samples (cold AIHA and warm AIHA with and without complement). In our novel flow cytometric indirect antiglobulin test (Flow IAT), bromelain-treated group O donor RBCs were incubated with serum from AIHA patients (n=48) or controls (n=21) in EDTA. Cells were washed and incubated with donor serum as complement source, with anti-C5 to prevent lysis. The RBCs were analyzed for IgM, IgG, C4 and C3 opsonization, using flow cytometry. IgM binding correlated strongly with C4 and C3 deposition, whereas IgG binding correlated poorly. The strong correlation between IgM and C4 remained when analyzing per AIHA subtype. The Flow IAT demonstrated enhanced sensitivity for detecting IgM antibodies compared to conventional diagnostics, while its sensitivity for IgG detection was lower. In conclusion, we developed the Flow IAT, a novel indirect serum-based assay using flow cytometry to quantify binding of circulating anti-RBC antibodies and antibody-mediated complement activation. The Flow IAT successfully identified the presence of complement-activating autoantibodies and demonstrated that IgM strongly correlated with complement activation in both cold and warm AIHA.
引用
- Mulder FV, De Boer EC, Kamp AM, et al. Novel flow cytometric assay 'Flow IAT' reveals hidden IgM driving complement activation in autoimmune hemolytic anemia. Blood Adv. 2026. PMID: 42962265. doi:10.1182/bloodadvances.2025019072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。